NeuroPace, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue22.1M26.6M27.4M23.5M22.5M21.5M21.1M19.3M
Cost of Goods Sold4.0M6.0M6.2M5.4M5.2M5.3M5.6M5.1M
Gross Profit18.0M20.6M21.2M18.1M17.3M16.2M15.4M14.1M
R&D Expenses7.2M7.0M6.6M6.8M7.4M6.0M5.8M6.1M
Operating Expenses23.6M22.3M23.8M25.0M22.5M19.8M19.7M20.4M
Operating Income-5.6M-1.8M-2.6M-6.8M-5.1M-3.7M-4.2M-6.2M
Other Income / Gains-1.1M-962K-896K-1.8M-1.4M-1.6M-1.2M-1.3M
Net Income-6.7M-2.7M-3.5M-8.7M-6.6M-5.3M-5.5M-7.5M
EPS (Diluted)-0.20-0.082-0.11-0.26-0.21-0.18-0.19-0.26
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.8180.7740.7740.7710.770.7540.7320.734
General And Administrative Expenses4.8M4.4M4.6M6.1M4.0M004.5M
Selling And Marketing Expenses11.6M10.9M12.6M12.0M11.0M009.8M
Selling General And Administrative Expenses16.4M15.3M17.2M18.1M15.0M13.8M13.9M14.3M
Other Expenses00000000
Cost And Expenses27.6M28.4M30.0M30.3M27.7M25.1M25.3M25.5M
Interest Income565K638K0718K793K681K754K762K
Interest Expense1.5M1.6M978K2.1M2.2M2.2M2.2M2.2M
Depreciation And Amortization513K522K54K477K462K451K451K444K
Ebitda-5.1M-1.2M-2.5M-6.1M-4.7M-2.6M-2.8M-4.9M
Ebitdaratio-0.229-0.047-0.09-0.26-0.208-0.121-0.134-0.255
Operating Income Ratio-0.252-0.066-0.095-0.29-0.229-0.17-0.201-0.324
Income Before Tax-6.7M-2.7M-3.5M-8.7M-6.6M-5.3M-5.5M-7.5M
Income Before Tax Ratio-0.303-0.103-0.128-0.368-0.293-0.245-0.259-0.39
Income Tax Expense00000000
Net Income Ratio-0.303-0.103-0.128-0.368-0.293-0.245-0.259-0.39
Epsdiluted-0.20-0.082-0.11-0.26-0.21-0.18-0.19-0.26
Weighted Average Shs Out33.7M32.7M33.1M32.9M31.5M29.9M29.4M28.9M
Weighted Average Shs Out Dil33.7M32.7M33.1M32.9M31.5M29.9M29.4M28.9M